Cold atmospheric pressure plasma elimination of clinically important single- and mixed-species biofilms. by Modic, M et al.
Corresponding authors: *Mark.Sutton@phe.gov.uk, +JLWalsh@Liverpool.ac.uk 
Cold atmospheric pressure plasma elimination of clinically important single and multi-
species biofilms  
Martina Modic1, 3, Neil P. McLeod2, J. Mark Sutton2*, James L. Walsh1+ 
1Department of Electrical Engineering and Electronics, University of Liverpool, Brownlow Hill, Liverpool 
L69 3GJ, United Kingdom. 
2Public Health England, Manor Farm Rd, Porton Down, Salisbury SP4 0JG, United Kingdom. 
3Department of Surface Engineering and Optoelectronics, Institute "Jozef Stefan", Jamova cesta 39, 
1000 Ljubljana, Slovenia. 
 
Abstract: Mixed species biofilms reflect the natural environment of many pathogens in clinical 
settings and are highly resistant to disinfection methods. An indirect cold atmospheric-
pressure, air-plasma system was evaluated, under two different discharge conditions, for its 
ability to kill representative Gram-positive (Staphylococcus aureus) and Gram-negative 
(Pseudomonas aeruginosa) pathogens. Plasma treatment of individual 24-hour biofilms and 
mixed species biofilms that contained additional species (Enterococcus faecalis and Klebsiella 
pneumoniae) was considered. Under plasma conditions that favoured the production of 
Reactive Nitrogen Species (RNS), individual P. aeruginosa biofilms containing approximately 
5.0 x 106 colony forming units (cfu) were killed extremely rapidly, with no bacteria survival 
detected at 15 seconds exposure. 
S. aureus survived longer under these conditions, with no detectable growth after 60 seconds 
exposure. In mixed species biofilms, P. aeruginosa survived longer, but all species were killed 
with no detectable growth at 60 seconds. Under plasma conditions that favoured the 
production of Reactive Oxygen Species (ROS), P. aeruginosa showed increased survival with 
the limit of detection reached by 120 seconds and S. aureus was killed in a similar time-frame. 
In the mixed species model, bacterial kill was biphasic but all pathogens showed viable cells 
after a 240 second exposure, with P. aeruginosa showing significant survival (approx. 3.6 ± 0.6 
x 106 cfu). Overall the study shows the potential of indirect air plasma treatment to achieve 
significant bacterial kill, but highlights aspects that might affect performance against key 
pathogens especially in real-life settings within mixed populations. 
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Highlights: 
 Indirect atmospheric pressure air plasma treatment was found to be an effective 
decontamination technique for biofilms grown on polymeric surfaces. 
 
 Mixed species biofilms showed increased resistance to plasma treatment, with viable 
bacteria remaining within the treatment time frame.   
 
 Variation in the reactive plasma chemistry was used to highlight the different 
sensitivities between the species within a mixed species biofilm.  
 
 
  
1. Introduction 
Cold atmospheric pressure plasma is an emerging technology that is currently under intense 
investigation for microbial decontamination applications [1]. A number of studies have 
highlighted the potential for plasmas to decontaminate a range of pathogens important in 
healthcare [1]. These studies have tested the efficacy of plasma against planktonic cells or 
single species biofilms [2, 3, 4]. However, in the environment biofilms are likely to exist as 
mixed microbial communities and studies have shown that mixed-species biofilms possess 
increased resistance to antimicrobial agents compared to single-species biofilms [5].  
Mixed-species biofilms are an important colonizer of a wide range of medical devices, such as 
venous and urinary catheters, mechanical heart valves, prosthetic joints and endotracheal 
tubes [6]. Common bacterial species isolated from medical devices include those termed 
‘ESKAPE’ pathogens (Enterococcus faecalis, Staphylococcus aureus, Klebsiella pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) [7]. Although by no 
means the only pathogens that form biofilms on medical devices, these organisms are 
associated with increasing levels of multidrug resistance (resistant to at least 3 classes of 
frontline antibiotic) and represent a serious public health threat [8]. A mixed-species biofilm 
consortium was selected for this study, based on the representation of the organisms in 
chronic wound infections and as common colonisers on implanted medical devices [9]. As such, 
the outputs of the study should be informative for the use of plasma systems to generate 
reactive species to control these types of bacterial infection in vivo. Plasma systems are 
already used for the treatment of wound infections [10]. 
An advantage of plasma decontamination is that it does not rely on any one mechanism for 
bacterial killing; Reactive Oxygen Species (ROS), Reactive Nitrogen Species (RNS), UV photons 
and high electric fields are all produced simultaneously in the plasma, increasing the potential 
for synergistic effects. This pilot study explores how the reactive chemistry produced by an 
indirect cold air plasma impacts the decontamination efficacy of two clinically relevant ESKAPE 
bacterial species (P. aeruginosa and S. aureus) in both single and mixed species biofilms.  
 
 
  
2. Materials and methods 
2.1. Bacterial strains and culture conditions 
Four different bacterial strains were included in this study: Pseudomonas aeruginosa 
(PAO1), Klebsiella pneumoniae (NCTC13368), Enterococcus faecalis (NCTC775) and 
Staphylococcus aureus (ATCC9144). Bacterial cultures were prepared in Tryptic Soy Broth 
(TSB) with shaking at 37 °C or incubated on Tryptic Soy Agar at 37 °C.  
 
2.2. Biofilm formation in the CDC biofilm reactor 
Biofilms were generated on PVC coupons in the CDC bioreactor (Bio Surface Technology 
Corp., Bozeman, MT, USA). P. aeruginosa and S. aureus were used to form single-species 
biofilm models. Bacteria at a final concentration of 1.0 x 105 cfu/mL were added to the 350 
ml of TSB medium. Biofilms were grown for 24 h at 37°C with stirring at 200 rpm. 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterococcus faecalis and 
Staphylococcus aureus were used in mixed-species biofilms [9]. 
 
2.3. Plasma source & sample exposure 
The plasma source considered in this study is similar to that reported by Olszweski et al. 
and employs a Surface Barrier Discharge (SBD) configuration as shown in Figure 1(a) [11]. 
Biofilm-containing coupons were removed from the bioreactor following incubation and 
rinsed twice in 25 mL sterile phosphate-buffered saline (PBS) to remove planktonic and 
loosely attached cells. Coupons were exposed to the plasma at a distance of 5 mm 
between the sample and the electrode. Two plasma powers were considered, a low power 
discharge, Pdischarge = 8 W, giving an ROS dominated gas phase chemistry and a high power 
discharge, Pdischarge = 34.5 W, giving an RNS dominated gas phase chemistry (discussed 
further in section 2). Treatments were performed for 7 seconds up to 240 seconds. 
Coupons were treated on both sides at the same plasma conditions. Treatment at each 
parameter was performed in triplicate with at least 3 replicates per experiment.    
  
2.4. Determination of biofilm elimination 
Bacterial survival after plasma exposure was determined by serial dilution with Miles-
Misra enumeration [9]. Treated PVC coupons were immediately transferred to 5 mL of TSB 
to quench any further inactivation and vigorously shaken for 10 min using a vibratory 
shaker (VXR basic Vibrax®, IKA, Staufen, Germany) at 2000 rpm to release cells. 10 µL of 
bacterial suspensions were added to 90 µL of fresh TSB medium. This was serially diluted 
ten-fold to 10-5 in 96-well plates. 10 µL of each dilution was plated on TSA plates, with 
three repetitions for each dilution. Controls followed the same protocols except for 
exposure to plasma. Plates were incubated overnight at 37 °C. The limit of detection was 
around 5.0 x 102 bacteria. 
  
2.5. Fourier transform infrared spectroscopy – FTIR 
FTIR was used for characterization of reactive species in the gas phase. The plasma 
generating electrodes were sealed in a box of similar volume to that used in the 
decontamination experiments from where the plasma exhaust gas was drawn in to a 10 
cm path length gas cell and analysed with a FT/IR-4200 (JASCO, Tokyo, Japan). A spectral 
resolution of 2.0 cm-1 was used and each absorption spectrum was acquired over 25 scans. 
The composition of the plasma effluent was analysed under the same conditions as those 
used in the biofilm deactivation experiments. 
 
3. Results 
3.1 Characterization of gas phase  
Figure 1(b) highlights the FTIR absorption spectrum under low and high power plasma 
generation conditions. FTIR analysis is only capable of identifying molecules that actively 
absorb in the IR range; hence, the data presented in Figure 1(b) should not be considered 
as an exhaustive characterisation of the plasma effluent. Under low plasma power 
conditions, ozone was found to dominate, indicating the predominance of ROS in this 
regime. Under high plasma power conditions, the oxides of nitrogen dominated, with no 
  
measurable ozone production; indicating the predominance of RNS. The variation in gas 
phase chemistry under different operating power conditions is typical for such a discharge 
and is attributed to elevated temperatures in the plasma, leading to thermal degradation 
of ozone and a thermally driven increase in nitric oxide production [11]. 
 
 
Figure 1: (a) Schematic of plasma system and sample position, (b) FTIR spectra obtained 
after 120 seconds of plasma generation under ROS dominant (black) and RNS dominant 
(red) conditions. 
 
3.2 Effect of plasma treatment on the survival of P. aeruginosa and S. aureus biofilms 
Single-species biofilms of P. aeruginosa and S. aureus were exposed to the ROS- and RNS-
dominant plasma effluent regimes over varying periods of time. The sensitivity of the two 
species to plasma elimination was different with respect to the respective discharge 
regimes and from one species to the other. Figure 2(a) shows the elimination rate of P. 
aeruginosa biofilm is strongly influenced by the dominant gas-phase chemistry. Under 
low-power, ROS-dominated conditions, elimination of the bacteria to below the limits of 
detection of the assay, was achieved within 120 seconds. In the high-power, RNS-
dominated regime, complete elimination of P. aeruginosa was achieved in less than 15 
seconds. Figure 2(b) highlights that plasma treatment was also efficient for the elimination 
of S. aureus biofilms. In contrast to P. aeruginosa, the S. aureus biofilms showed little 
dependency on the plasma generation conditions. Thus the rate of elimination of the 
bacteria was similar across the first 30 seconds of exposure. Thereafter the RNS-
dominated effluent was able to kill S. aureus to below the detection limit of the assay 
within 60 seconds, whereas this was only achieved by 120 seconds in the ROS dominated 
  
case. In comparison between the two bacteria, P. aeruginosa was significantly more 
sensitive to the RNS-dominated regime than S. aureus, whilst the reverse was true for the 
ROS-dominated conditions, albeit with the two bacteria showing very different kill kinetics. 
 
 
Figure 2: Elimination of single species biofilms under low and high power plasma 
conditions: (a) P. aeruginosa and (b) S. aureus. Each data point represents the mean cfu 
for each time point with error bars representing standard deviation. The mean and 
standard deviation are calculated from all replicate cfu count values for each of the 
triplicate experiments (n=9). Statistically significant differences between elimination 
under low and high power conditions were determined using a one-way ANOVA (IBM 
SPSS Statistics 22), with Scheffe’s posthoc test (*p<0.05). 
 
3.3 Effect of plasma treatment on the survival of mixed-species biofilms 
Mixed-species biofilms contained P. aeruginosa, S. aureus, K. pneumoniae and E. faecalis 
strains [9]. This system provides similar numbers of the 4 species, when used at 24 hours, 
and provides a basis to compare relative elimination within a single co-culture system. 
The treatment conditions were the same as described for single-species biofilms. The 
susceptibility of P. aeruginosa and S. aureus was found to be different within the 
multispecies communities compared to that observed in single-species biofilms; 
highlighted in Figures 3(a) and 3(b), for ROS and RNS dominated regimes, respectively. 
Under ROS exposure, there was a biphasic kill of the bacteria, with only a small reduction 
  
in viable count, of the order of 1-2 logs, after 60 seconds exposure. Between 60 and 120 
seconds, three of the species, S. aureus, E. faecalis and K. pneumoniae showed a further 
reduction in viable count of around 2-logs, but there were still viable bacteria after 240 
seconds exposure. P. aeruginosa showed a much more gradual reduction in viable count 
and there was less than a 3-log reduction achieved in total across the 240 second 
exposure regime. P. aeruginosa and to a lesser extent S. aureus were less susceptible to 
kill under ROS-dominated plasma conditions in mixed culture than in single species 
biofilms. After exposure to an RNS-dominated effluent, the two Gram-negative species, 
P. aeruginosa and K. pneumoniae were reduced to below the limits of detection of the 
assay by 30 seconds and E. faecalis was reduced to levels only just above the LoD. At this 
time point, S. aureus in the mixed species model was reduced by only 3-logs.   
 
 
Figure 3: Elimination of mixed species biofilms under: (a) ROS dominated conditions and 
(b) RNS dominated conditions. Each data point represents the mean cfu for each time 
point with error bars representing standard deviation. The mean and standard deviation 
are calculated from all replicate cfu count values for each of the triplicate experiments 
(n=9). Statistically significant differences between species elimination at a given time 
were determined using a one-way ANOVA (IBM SPSS Statistics 22) with Scheffe’s 
posthoc test (*p<0.05).  
 
  
4. Discussion  
This study demonstrates that indirect air plasma exposure can achieve effective kill of a range 
of different clinically-important pathogens, even in mixed-species biofilms. As these are 
commonly encountered in a variety of clinical settings, and are, perhaps, the most resistant 
form of bacterial colonisation on surfaces, this preliminary study offers significant potential 
for new applications. The differential sensitivity with respect to varying gas phase chemistries 
suggests that specific plasma species are important for killing specific pathogens and this may 
be influenced by the biofilm environment. Importantly, this information guides the potential 
development of plasma systems for the treatment of these complex biofilms in clinical settings, 
such as diabetic foot ulcers and biofilm-colonised implanted medical devices. Plasma systems 
which generate bactericidal reactive species, of the type observed here, could provide 
valuable alternatives to drug therapy for topical treatment of infections, which would 
contribute to antibiotic stewardship endeavours.  
 
P. aeruginosa is an archetypal biofilm-forming bacterium, producing complex biofilms with 
significant amounts of extracellular matrix material (exopolysaccharide and DNA). Although 
the 24 hour biofilms used in this study are relatively simple, it was clear that the P. aeruginosa 
biofilm was significantly more susceptible to the species released under RNS-dominated 
conditions than was S. aureus. This is consistent with observations from other studies using 
atmospheric plasma systems (e.g. helium:oxygen plasma [4]) which showed that P. 
aeuruginosa was significantly more susceptible than S. aureus. Under ROS-dominated 
conditions, P. aeruginosa is much less susceptible and the differences between plasma 
conditions in susceptibility with S. aureus are less distinct. There is evidence to suggest that 
RNS may kill Pseudomonas in biofilms and, at low dose, also disrupt their structure to allow 
improved access for other molecular species [12, 13]. Similar effects generated by plasma-
derived species might explain the observations in this study and why the difference is less 
marked under lower power conditions, where ROS predominate, both in the gas and water 
phase.  
 
The results of this study confirm that the kinetics of bacterial kill will be more complex in 
mixed-species biofilm systems, even in relatively immature biofilms. Under RNS-dominated 
  
conditions, in mixed-species models, there is a small reduction in the susceptibility of P. 
aeruginosa, but S. aureus is essentially unaffected. This suggests that there is free penetration 
of RNS into the mixed species biofilm and that there is not significant turnover of such species 
by bacterial RNS defences within the time-course used. This is not the case under ROS 
dominated conditions, where all the species were able to survive to 240 seconds exposure 
and there were significantly reduced levels of kill for P. aeruginosa. This suggests poor 
penetration of ROS, compared to the single species biofilms for P. aeruginosa and S. aureus, 
and/or that catalases and superoxide dismutases expressed in the mixed-species model, 
significantly reduce the local levels of ROS. The biphasic profile of the survival curves also 
suggests that there may be issues with penetration with freely accessible cells being killed 
rapidly whilst less accessible cells only being killed by prolonged exposure if at all. That P. 
aeruginosa is the species that benefits most from the mixed-species culture may reflect it 
occupying a more protected niche (e.g. closer to the solid support) within the biofilm or that 
its oxidative defences are activated more strongly in such biofilms than in single species 
systems. The results are consistent with previous studies, showing that P. aeruginosa was the 
organism most able to survive chlorhexidine exposure within the mixed-species model [9]. 
 
The study provides strong evidence that defined configurations of atmospheric pressure air 
plasmas can achieve rapid and highly effective bacterial kill in complex models. This brief study 
starts to define some of the key research questions in terms of optimising plasma discharges 
to generate, perhaps, more RNS species. It also identifies fundamental gaps in our 
understanding of the architecture of co-cultured biofilms and the cross-dependency of 
individual species within it.   
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